Leprosy Mailing List – February 2nd, 2010
Ref.: Alternative antibiotic regimens for leprosy
From: Wim H. van Brakel,
Dear Dr. Gilead,
Thank you for your response (LML Jan. 27th, 2010).
If patients are also unable to take dapsone or are dapsone resistant, that of course changes matters considerably. Such patients should be given at least one alternative effective antibiotic. I would fully support the combination suggested by Prof. Diana Lockwood in an earlier contribution (LML Jan. 27th, 2010). I do not have personal experience with moxifloxacin or clarithromycin. There is (some) evidence of their efficacy, but they are very likely much more expensive than ofloxacin or minocyclin.
I do not see why Ethiopian patients should have a higher rate of dapsone resistance than patients from elsewhere.
I hope this helps!
With kind regards,
Wim
Wim H. van Brakel
Royal Tropical Institute
Leprosy Unit
and
Athena Institute
Faculty of Earth and Life Sciences
VU University
Correspondence address:
Wibautstraat 137k
1097DN
tel +3120 6939297
fax +3120 6680823
w.v.brakel(at)kit.nl
wim.van.brakel(at)falw.vu.nl
No comments:
Post a Comment